SCICLONE PHARMACEUTICALS INC Net Income
SCICLONE PHARMACEUTICALS INC reported Net Income of $12.19 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2017-08-09
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2017-06-30 was $12.19M, a 92.36% increase year-over-year.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2017-03-31 was $14.60M, a 85.61% increase year-over-year.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2016-12-31 was $6.41M, a 48.89% decline year-over-year.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2016-09-30 was $10.12M, a 15.55% decline year-over-year.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2016 was $30.73M, a 4.30% increase from fiscal 2015.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2015 was $29.46M, a 16.88% increase from fiscal 2014.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2014 was $25.21M, a 129.92% increase from fiscal 2013.
- SCICLONE PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2013 was $10.96M, a 13.97% increase from fiscal 2012.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $12.19M 10-Q · filed 2017-08-09 | $26.79M 10-Q · filed 2017-08-09 | $33.20M derived: sum of 3 quarters · filed 2017-08-09 | $43.31M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2017-03-31 | $14.60M 10-Q · filed 2017-05-10 | $21.01M derived: sum of 2 quarters · filed 2017-05-10 | $31.12M derived: sum of 3 quarters · filed 2017-05-10 | $37.46M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-12-31 | $6.41M 10-K · filed 2017-03-09 | $16.53M derived: sum of 2 quarters · filed 2017-03-09 | $22.86M derived: sum of 3 quarters · filed 2017-08-09 | $30.73M 10-K · filed 2017-03-09 | ||||
| 2016-09-30 | $10.12M 10-K · filed 2017-03-09 | $16.45M derived: sum of 2 quarters · filed 2017-08-09 | $24.32M 10-Q · filed 2016-11-09 | $36.86M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-06-30 | $6.34M 10-Q · filed 2017-08-09 | $14.20M 10-Q · filed 2017-08-09 | $26.75M derived: sum of 3 quarters · filed 2017-08-09 | $38.73M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $7.86M 10-Q · filed 2017-05-10 | $20.41M derived: sum of 2 quarters · filed 2017-05-10 | $32.39M derived: sum of 3 quarters · filed 2017-05-10 | $28.36M derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $12.54M 10-K · filed 2017-03-09 | $24.52M derived: sum of 2 quarters · filed 2017-03-09 | $20.50M derived: sum of 3 quarters · filed 2017-03-09 | $29.46M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $11.98M 10-K · filed 2017-03-09 | $7.96M derived: sum of 2 quarters · filed 2017-03-09 | $16.92M 10-Q · filed 2016-11-09 | $20.44M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2015-06-30 | -$4.02M 10-K · filed 2017-03-09 | $4.94M 10-Q · filed 2016-08-09 | $8.46M derived: sum of 3 quarters · filed 2017-03-09 | $16.37M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2015-03-31 | $8.96M 10-K · filed 2017-03-09 | $12.48M derived: sum of 2 quarters · filed 2017-03-09 | $20.40M derived: sum of 3 quarters · filed 2017-03-09 | $30.04M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2014-12-31 | $3.52M 10-K · filed 2016-03-11 | $11.43M derived: sum of 2 quarters · filed 2016-03-11 | $21.07M derived: sum of 3 quarters · filed 2016-03-11 | $25.21M 10-K · filed 2017-03-09 | ||||
| 2014-09-30 | $7.92M 10-K · filed 2016-03-11 | $17.55M derived: sum of 2 quarters · filed 2016-03-11 | $21.69M 10-Q · filed 2015-11-09 | $21.73M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $9.64M 10-K · filed 2016-03-11 | $13.77M 10-Q · filed 2015-08-10 | $13.81M derived: sum of 3 quarters · filed 2016-03-11 | $22.52M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $4.13M 10-K · filed 2016-03-11 | $4.17M derived: sum of 2 quarters · filed 2016-03-11 | $12.88M derived: sum of 3 quarters · filed 2016-03-11 | $10.89M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $36.00K 10-K · filed 2015-03-12 | $8.74M derived: sum of 2 quarters · filed 2015-03-12 | $6.76M derived: sum of 3 quarters · filed 2015-03-12 | $10.96M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $8.71M 10-K · filed 2015-03-12 | $6.72M derived: sum of 2 quarters · filed 2015-03-12 | $10.93M 10-Q · filed 2014-11-10 | $12.82M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$1.98M 10-K · filed 2015-03-12 | $2.22M 10-Q · filed 2014-08-11 | $4.11M derived: sum of 3 quarters · filed 2015-03-12 | -$9.05M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $4.20M 10-K · filed 2015-03-12 | $6.09M derived: sum of 2 quarters · filed 2015-03-12 | -$7.07M derived: sum of 3 quarters · filed 2015-03-12 | $4.16M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $1.89M 10-K · filed 2014-03-17 | -$11.27M derived: sum of 2 quarters · filed 2014-03-17 | -$45.00K derived: sum of 3 quarters · filed 2014-03-17 | $9.62M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | -$13.16M 10-K · filed 2014-03-17 | -$13.54M 10-Q · filed 2012-11-09 | -$1.93M derived: sum of 2 quarters · filed 2014-03-17 | $7.73M 10-Q · filed 2013-11-12 | $5.76M 10-Q · filed 2012-11-09 | $19.28M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $11.23M 10-K · filed 2014-03-17 | $10.62M 10-Q · filed 2012-08-08 | $20.89M 10-Q · filed 2013-08-09 | $19.30M 10-Q · filed 2012-08-08 | $32.44M derived: sum of 3 quarters · filed 2014-03-17 | $43.27M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $9.66M 10-K · filed 2014-03-17 | $8.68M 10-Q · filed 2012-05-10 | $21.21M derived: sum of 2 quarters · filed 2014-03-17 | $32.05M derived: sum of 3 quarters · filed 2014-03-17 | $33.94M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | $11.55M 10-K · filed 2013-04-01 | $22.38M derived: sum of 2 quarters · filed 2013-04-01 | $24.27M derived: sum of 3 quarters · filed 2013-04-01 | $28.12M 10-K · filed 2014-03-17 | $28.46M 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $10.83M 10-Q/A · filed 2013-04-01 | $10.23M 10-Q · filed 2011-11-09 | $12.72M derived: sum of 2 quarters · filed 2013-04-01 | $16.57M 10-Q/A · filed 2013-04-01 | $16.06M 10-Q · filed 2011-11-09 | $20.35M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-06-30 | $1.89M 10-Q/A · filed 2013-04-01 | $1.98M 10-Q · filed 2011-08-09 | $5.74M 10-Q/A · filed 2013-04-01 | $5.83M 10-Q · filed 2011-08-09 | $9.52M derived: sum of 3 quarters · filed 2013-04-01 | $17.15M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-03-31 | $3.85M 10-Q/A · filed 2013-04-01 | $7.63M derived: sum of 2 quarters · filed 2013-04-01 | $15.26M derived: sum of 3 quarters · filed 2013-04-01 | $20.74M derived: sum of 4 quarters · filed 2013-04-01 | ||||
| 2010-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $11.41M derived: sum of 2 quarters · filed 2013-04-01 | $16.89M derived: sum of 3 quarters · filed 2013-04-01 | $21.08M 10-K · filed 2013-04-01 | ||||
| 2010-09-30 | $7.63M 10-Q · filed 2011-11-09 | $13.11M derived: sum of 2 quarters · filed 2011-11-09 | $17.30M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $5.48M 10-Q · filed 2011-08-09 | $9.67M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $11.95M 10-K · filed 2012-03-15 |